NEW YORK (GenomeWeb News) — GeneGo today said it will work with the Cystic Fibrosis Foundation to develop a software suite to handle data from cystic fibrosis drug-development studies.  
 
The new platform, called MetaMiner, will include off-the-shelf GeneGo products such as MetaCore, MetaDrug, MetaLink, and MapEditor. MetaMiner will include -omics and small experiments specific to cystic fibrosis that have been annotated by GeneGo.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.